BioLegacy Research Passes USDA Inspection with Zero Findings

San Diego, CA – September 18, 2025 – BioLegacy Research, a leading contract research organization (CRO) specializing in preclinical services in regulated species (including rodents, dogs, minipigs, NHPs), is pleased to announce the successful completion of its recent USDA inspection, which concluded with zero findings.

The inspection, conducted on September 2, 2025, reaffirms BioLegacy Research’s ongoing commitment to the highest standards of quality, compliance, and animal welfare. The USDA’s thorough review identified no concerns, underscoring the organization’s dedication to operational excellence and regulatory integrity.

For more information about BioLegacy Research and its comprehensive services from Discovery to IND, please visit https://biolegacy.biobm.com/

DOWNLOAD THE USDA INSPECTION REPORT >>

About BioLegacy Research:

BioLegacy Research is a San Diego-based preclinical CRO that delivers GLP and Non-GLP biological services to clients in pharmaceutical, biopharmaceutical, biotech, academic research, medical device, and related industries with an extensive track record of conducting 1000’s of studies and 100’s of IND enabling studies with roots dating back to 2001 when they acquired Bio-Quant in 2011.

‘For more information on BioLegacy Research,  visit https://biolegacy.biobm.com/